Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Infect Public Health ; 15(6): 677-684, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35623242

RESUMO

BACKGROUND: Antibiotic-resistant Acinetobacter baumannii is a continuously-emerging worldwide health crisis, with mortality rates approaching 50% in intensive care unit (ICU) patients. The objective of this study was to evaluate regional, patient-related, and organism-related predictors of survival among critically-ill patients with confirmed Acinetobacter infection. METHODS: This prospective cohort study was conducted within ten ICUs across six geographically- and climatologically-distinct cities across Saudi Arabia over 13 months. RESULTS: Of 169 patients with confirmed Acinetobacter infection enrolled in the study, 80 (47.6%) died. Survivors were statistically younger, predominantly male, more likely to be admitted for trauma, less likely to have hypertension, diabetes, or have undergone hemodialysis, and more likely to have been treated with antibiotics prior to having a positive culture for Acinetobacter, but less likely to have received an aminoglycoside. Survivors also had lower baseline APACHE II and SOFA scores and were infected with stains of Acinetobacter that had less meropenem- or colistin-resistance. Multivariate analysis identified the following independent predictors of survival: younger age, lower ICU-day#1 APACHE-II and ICU-day#3 SOFA scores, being admitted for trauma, and having no history of hemodialysis. CONCLUSIONS: Patient-related factors outweigh regional and hospital-related factors as predictors of survival among critically-ill patients with Acinetobacter infection.


Assuntos
Infecções por Acinetobacter , Acinetobacter baumannii , Humanos , Masculino , Feminino , Estudos de Coortes , Arábia Saudita/epidemiologia , Infecções por Acinetobacter/tratamento farmacológico , Infecções por Acinetobacter/epidemiologia , Estudos Prospectivos , Estado Terminal , Cidades , Antibacterianos/uso terapêutico , Unidades de Terapia Intensiva , Estudos Retrospectivos
2.
J Crit Care ; 66: 109-116, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34508982

RESUMO

BACKGROUND: Acinetobacter is an increasingly-problematic organism, especially in intensive care units (ICUs). In this study, we compared its incidence, outcomes, and predictors spanning eight ICUs in five geographically and climatologically-diverse cities in Saudi Arabia. METHODS: Geographic, climatologic, hospital-related, and patient-related factors were collected prospectively on 3179 patients admitted to eight Saudi ICUs from June 2018 through June 2019. These data then underwent both bivariable and multivariable analysis, the latter vis hierarchical logistic regression to identify predictors of clinically-manifest Acinetobacter infection. RESULTS: Overall incidence of Acinetobacter infection was 3.9% (n = 124). Of these 124 infections, 122 (98.4%) were cultured as A. baumannii. Incidence ranged from 1.0 to 7.9% across the eight ICUs. On bivariable analysis, incident Acinetobacter infection was more common in university and military hospitals, in hospitals with more total beds and ICU isolation rooms, and in 2018 versus 2019, incidence steadily declining over the 13 study months. Mechanically-ventilated patients had ten-fold increased odds of infection. Adjusted (multivariable) analysis revealed the risk of clinically-manifest Acinetobacter infection to increase the longer patients were on mechanical ventilation. Increased risk also existed at certain hospitals over others, especially in university-affiliated and military hospitals, larger hospitals with more isolation rooms, and hospitals with fewer ICU beds. CONCLUSION: In our study of eight ICUs across Saudi Arabia, inter-hospital differences did appear to account for inter-hospital differences in Acinetobacter incidence rates. Patients requiring mechanical ventilation for longer periods of time were particularly at risk.


Assuntos
Infecções por Acinetobacter , Acinetobacter baumannii , Infecção Hospitalar , Infecções por Acinetobacter/epidemiologia , Cuidados Críticos , Infecção Hospitalar/epidemiologia , Humanos , Incidência , Unidades de Terapia Intensiva , Fatores de Risco , Arábia Saudita/epidemiologia
3.
Paediatr Anaesth ; 19(4): 396-401, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19335348

RESUMO

We report the use of intravenous Methylene blue to treat the hypotension occurring following adrenal vein ligation in a case of pheochromocytoma resection in a child. The potential benefits and problems, including correct dosage, are discussed.


Assuntos
Neoplasias das Glândulas Suprarrenais/cirurgia , Hipotensão/tratamento farmacológico , Complicações Intraoperatórias/tratamento farmacológico , Azul de Metileno/uso terapêutico , Feocromocitoma/cirurgia , Criança , Hemodinâmica/fisiologia , Humanos , Hipotensão/fisiopatologia , Hipovolemia/complicações , Complicações Intraoperatórias/fisiopatologia , Masculino , Obesidade/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA